<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">SMF</journal-id>
      <journal-title-group>
        <journal-title>Schweizerisches Medizin-Forum</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1424-4020</issn>
      <issn pub-type="ppub">1424-3784</issn>
      <publisher>
        <publisher-name>EMH Schweizerischer Ärzteverlag AG</publisher-name>
        <publisher-loc>Farnsburgerstrasse 8
CH-4132 Muttenz</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">08071</article-id>
      <article-id pub-id-type="doi">10.4414/smf.2019.08071</article-id>
      <article-categories>
        <!-- rubric -->
        <subj-group subj-group-type="Article Type">
          <subject>Der besondere Fall</subject>
        </subj-group>
        <!-- topics -->
        <subj-group subj-group-type="Classification">
          <subject>Endokrinologie / Diabetologie und Stoffwechsel </subject>
          <subject>Kardiologie</subject>
          <subject>Klinische Pharmakologie und Toxikologie</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Eine vermeintliche Addison-Krise</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Walter</surname>
            <given-names>Martin</given-names>
          </name>
          <email>martin.walter@stgag.ch</email>
          <aff>Spitalcampus 1 | Münsterlingen | 8596 | SWITZERLAND</aff>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Hübner</surname>
            <given-names>Tobias</given-names>
          </name>
          <email/>
          <aff>Anästhesie, Intensivmedzin, Operationszentrum &amp; Schmerzmedizin AIOS, Kantonsspital Münsterlingen</aff>
        </contrib>
        <contrib id="author-3" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Pavlicek</surname>
            <given-names>Vojtech</given-names>
          </name>
          <email/>
          <aff>Endokrinologie, Diabetologie und klinische Ernährung, Medizinische Klinik, Kantonsspital Münsterlingen</aff>
        </contrib>
        <contrib id="author-4" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Walser</surname>
            <given-names>Daniel</given-names>
          </name>
          <email/>
          <aff>Endokrinologie, Diabetologie und klinische Ernährung, Medizinische Klinik, Kantonsspital Münsterlingen</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2019.07.17">
        <day>17</day>
        <month>07</month>
        <year>2019</year>
      </pub-date>
      <volume>19</volume>
      <issue>2930</issue>
      <fpage>489</fpage>
      <lpage>491</lpage>
      <permissions>
        <copyright-statement>Copyright: EMH Schweizerischer Ärzteverlag AG</copyright-statement>
        <copyright-year>2019</copyright-year>
        <copyright-holder>EMH Schweizerischer Ärzteverlag AG</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>"Swiss Medical Forum" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:</license-p>
          <license-p>Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</license-p>
          <license-p>NonCommercial — You may not use the material for commercial purposes.</license-p>
          <license-p>NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.</license-p>
          <license-p>"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.</license-p>
          <license-p>Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="article" xml:lang="de">&lt;p&gt;Bei einer schweren Hypotonie sollte immer auch an eine Intoxikation mit Antihypertensiva gedacht werden, insbesondere wenn keine Hinweise f&amp;uuml;r einen Infekt, eine kardiale Genese oder Hypovol&amp;auml;mie vorliegen. Die Diagnosestellung einer Intoxikation kann sehr schwierig sein und erfordert bei mangelnder Kooperation seitens des Patienten ein besonderes Fingerspitzengef&amp;uuml;hl und sorgf&amp;auml;ltige Aufarbeitung. Bei einer prim&amp;auml;ren Nebennierenrindeninsuffizienz zeigt sich ein erh&amp;ouml;htes Renin bei einem Aldosteron im tiefnormalen oder erniedrigtem Bereich. Bei einer sekund&amp;auml;ren Nebennierenrindeninsuffizienz hingegen ist das Renin und Aldosteron meist normal, da das Renin-Angiotensin-Aldosteron-System nicht beeintr&amp;auml;chtigt wird.&lt;/p&gt;</abstract>
    </article-meta>
  </front>
  <body/>
  <back/>
</article>
